Promoted
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Allergan is a drug manufacturers-general business based in the US. Allergan stocks (AGN.US) are listed on the NYSE and all prices are listed in US Dollars. Allergan employs 17,400 staff and has a trailing 12-month revenue of around $16.1 billion.
How to buy Allergan stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Promoted
Finder Award
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Allergan?
- Allergan shares summary
- Compare share dealing platforms
- Is Allergan stock a buy or sell?
- Is Allergan suitable for ethical investing?
- Are Allergan shares over-valued?
- Allergan's financials
- How volatile are Allergan shares?
- Does Allergan pay a dividend?
- Have Allergan shares ever split?
- Other common questions
Allergan stock price (NYSE:AGN)
Use our graph to track the performance of AGN stocks over time.Allergan shares at a glance
Information last updated 2020-06-08.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $188.84 |
| 200-day moving average | $187.66 |
| Wall St. target price | $188.33 |
| PE ratio | N/A |
| Dividend yield | $2.96 (1.53%) |
| Earnings per share (TTM) | $-25.50 |
Buy Allergan stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
1 - 5 of 5
Is it a good time to buy Allergan stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Allergan stock undervalued or overvalued?
Valuing Allergan stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Allergan's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Allergan financials
| Revenue TTM | $16.1 billion |
|---|---|
| Operating margin TTM | 6.85% |
| Gross profit TTM | $13.7 billion |
| Return on assets TTM | 0.74% |
| Return on equity TTM | -4.15% |
| Profit margin | -15.44% |
| Book value | $175.91 |
| Market capitalisation | $63.7 billion |
TTM: trailing 12 months
Allergan's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Allergan.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Allergan's total ESG risk score
Total ESG risk: 39.22
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Allergan's overall score of 39.22 (as at 01/01/2019) is pretty weak – landing it in it in the 68th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Allergan is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Allergan's environmental score
Environmental score: 5.79/100
Allergan's environmental score of 5.79 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Allergan is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Allergan's social score
Social score: 24.75/100
Allergan's social score of 24.75 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Allergan is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Allergan's governance score
Governance score: 16.68/100
Allergan's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Allergan is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Allergan's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Allergan scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Allergan hasn't always managed to keep its nose clean.
Allergan share dividends
We're not expecting Allergan to pay a dividend over the next 12 months.
Have Allergan's shares ever split?
Allergan's shares were split on a 2:1 basis on 30 October 1997. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Allergan shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Allergan shares which in turn could have impacted Allergan's share price.
Allergan share price volatility
Over the last 12 months, Allergan's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Allergan's is 1.1992. This would suggest that Allergan's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Allergan overview
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, central nervous system, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; In addition, it develops medical and cosmetic treatments; treatments for neurodegenerative disorders; and inflammatory and fibrotic diseases. It has a collaboration, option, and license agreement with Lyndra, Inc. to develop orally administered products for the treatment of Alzheimer's disease; strategic alliance and option agreement with Editas Medicine, Inc. ; and Allergan plc also has licensing agreements with Assembly Biosciences, Inc.
Stocks similar to Allergan
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Best bad credit loans in PEI
Compare some of the best bad credit loans in PEI.
-
Credito review
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
-
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
-
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
-
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
-
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.